Mature forms of the microRNAs miR-96, -182, and -183 originate from a single genomic locus and have been shown to be elevated approximately 50-fold in the livers of sterol regulatory elementbinding protein-1a and -2 (SREBP-1a and -2) transgenic mice. Our study attempted to identify the possible targets of these microRNAs using miRNA target prediction software. This revealed putative sites in insulin-induced genes (INSIGs). The 3 ′ untranslated region (UTR) of insulininduced gene 1 (INSIG1) contained sites corresponding to miR-182, and -183, while the 3 ′ UTR of INSIG2 featured an miR-96 site. Among these putative sites, only miR-96 demonstrated an inhibitory effect that was specific to the 3 ′ UTR of INSIG2. As INSIG proteins are the main components of SREBP cleavage complexes that act to release active SREBPs, we assessed the effects of miR-96 on INSIG and SREBP levels and activities. We found that miR-96 reduced the levels of INSIG2 in INSIG1 knockout human fibroblasts, resulting in an increase in SREBP-1 and -2 nuclear forms and a subsequent increase in the abundance of the mRNA of their target genes. These results suggest that miR-96, an miRNA induced by SREBP-2 activation, regulates downstream targets of SREBPs and may increase the abundance of active SREBP.
Introduction
Cholesterol and fatty acids are the main components of cell membranes and are primarily synthesized from acetyl-CoA. The enzymes responsible for de novo cholesterol and fatty acid synthesis are regulated by sterol regulatory element-binding proteins (SREBPs). Three isoforms of SREBPs have been identified in mammals, SREBP-1a, -1c, and -2. SREBP-1c and SREBP-2 are the most prevalent isoforms found in adult tissue and are produced as inactive precursors. These are typically found as integral membrane proteins in the endoplasmic reticulum (ER). SREBPs contain an N-terminal transcription factor region that is released in the Golgi apparatus by two proteases, site-1 (S1P) and site-2 protease (S2P). This cleaved region moves to the nucleus where it activates target genes by binding sterol response elements (SREs). SREBP-1c preferentially regulates genes involved in fatty acid and triglyceride synthesis, while SREBP-2 activates genes involved in cholesterol synthesis, low-density lipoprotein receptors, and PCSK9 Horton & Shimomura 1999; Horton et al. 2002) .
N-terminal cleavage of these SREBPs is regulated by several accessory proteins, such as SREBP cleavage activating protein (SCAP), insulin-induced gene 1 (INSIG1), and INSIG2. In situations where there is sufficient ER cholesterol, INSIGs bind to SCAP and prevent the SCAP-SREBP complex from moving to the Golgi apparatus Yang et al. 2002) . However, when cholesterol is low in the ER, SCAP undergoes a conformational change that results in dissociation from INSIG proteins. This enables SCAP-SREBP to be incorporated into COP-IIcoated vesicles that move to the Golgi apparatus, where the N-terminal region of SREBP is released (Sun et al. 2005) . Free INSIG1 that dissociates from SCAP undergoes rapid ubiquitin-mediated proteosomal degradation, while INSIG2 has a longer half-life and is not regulated by sterols Lee et al. 2006) .
The target genes of each SREBP isoform have been identified through the study of livers from three types of mice that either overexpress nSREBP-1a (TgSREBP1a), overexpress nSREBP-2 (TgSREBP-2), or are liverspecific SCAP knockouts (KO) (Scap −/− ) that have reduced expression for all SREBPs in liver (Shimano et al. 1996; Horton et al. 1998; Matsuda et al. 2001) . In particular, genes that encode enzymes required for fatty acid and cholesterol synthesis were identified as the likely targets for SREBP-1 and -2, respectively Horton et al. 2003) . Additionally, SREBPs can also regulate non-coding RNAs. For example, a polycistronic microRNA (miRNA) locus that contains miR-96, -182, and -183 was identified as a non-coding RNA region that is directly activated by SREBP-2 (Jeon et al. 2013 , respectively. On days 1 and 2, cells were transfected with 20 nM mirVANA miRNA mimics and 20 μL Lipofectamine RNAiMAX (Life Technologies) per plate. On day 3, cells were harvested and the membrane and nuclear proteins, and total RNA, were prepared as described previously . A 30 μg aliquot of protein from each sample was subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblots using antibodies raised against INSIG1 (13F5), INSIG2 (17H1), SREBP-1 (20B12), SREBP-2 (22D5), SCAP, cAMP response element-binding protein, and calnexin (Jo, Lee et al. 2011; Moon et al. 2012; Jo et al. 2013; Rong et al. 2017) . Total RNA was isolated using an RNA STAT solution and treated with DNaseI from a DNA-free kit (Ambion). cDNA was synthesized using a TaqMan Reverse Transcription Kit (Life Technologies). Real-time qPCR was performed using 2×SYBR Green PCR Master Mix (Life Technologies), as previously described (Liang et al. 2002) .
Results miR-96 levels were not regulated by insulin miR-96 was previously identified as a miRNA originating from the polycistronic miRNA locus that also contains miR-182 and -183. This miRNA has previously been shown to be highly elevated (approximately 50-fold) in the livers of TgSREBP-1a, and TgSREBP-2 transgenic mice when compared to wild-type (WT) (Jeon et al. 2013) . To determine whether insulin also regulates miR-96, levels of the miRNA were measured in livers of mice fasted for 12 h (low insulin) and mice refed a high carbohydrate diet for 12 h after 12 h of fasting (high insulin). No significant changes were detected in the levels of mature miR-96 between the fasting and refeeding periods (Figure 1(A)) . The basal expression level of miR-96 was extremely low in WT mice but there was no further reduction in miR-96 levels in Scap −/− mice compared to WT. This suggests that SREBPs are not critical to the maintenance of basal levels of miR-96 (Figure 1  (B) ). These results also indicate that short-term changes in insulin level do not play a significant role in regulating miR-96.
The 3 ′ ′ ′ ′ ′ UTR of INSIG2 is inhibited by miR-96
Targetscan and miRDB software were used to search for the target genes of miR-96, -182, and -183. This identified putative binding sites for miR-96 in the 3 ′ UTR of INSIG1 and for miR-183 in the 3 ′ UTR of INSIG2. Furthermore, these sites were found to be conserved in the mouse and rat genomes (Figure 2(A) ). Putative binding sites for miR-182 were also identified in the 3 ′ UTR of human and mouse INSIG1 (Figure 2(A) ). To determine whether the putative binding sites for miR-96, -182, and -183 in the 3 ′ UTRs of INSIG1 and INSIG2 were regulated by miRNAs, we cloned a 500 bp region from INSIG1 and INSIG2 containing these binding sites into a pmirGLO plasmid downstream of a firefly luciferase reporter gene. The 3 ′ UTR of FOXO1 was used as a positive control (Guttilla & White 2009; Myatt et al. 2010) . CHO-K1 cells were co-transfected with each plasmid and miR-96, -182, and -183 mimics. The firefly luciferase activity of each cell extract was then measured. This revealed that the luciferase activity of pFOXO1 was significantly inhibited by the presence of miR-96, -182, and -183. The luciferase activity of the pINSIG2 plasmid was inhibited by approximately 50% in cells transfected with miR-96, even when using concentrations as low as 1 nM. The inhibitory effects of miR-96 were abolished when the putative binding site for miR-96 was deleted from the 3 ′ UTR of INSIG2 (Figure 2(C) levels of SCAP (Figure 3) . However, we found that adding miR-96 did not affect INSIG1 levels in INSIG2-KO cells and there was no subsequent effect on SREBP activation. Changes in the expression of the target genes of SREBP-1 and SREBP-2 were also assessed in INSIG1-KO cells transfected with miR-96 or miR-NC (Figure 3 ). These genes are primarily involved in the cholesterol synthesis pathway and include 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) synthase and HMG-CoA reductase. We found that the transcript levels of these genes were increased fourfold to sixfold in INSIG1-KO cells exposed to miR-96. Additionally, transcripts for genes involved in the fatty acid synthesis pathway, such as FAS, SCD-1, and ELOVL6, were increased twofold to fourfold in cells transfected with miR-96, alongside an increase in SREBP activation (Figure 4) . These results suggested that miR-96 can inhibit endogenous INSIG2 and consequently enhance SREBP processing, leading to increased expression of SREBP target genes.
Discussion
The roles of SREBPs in the regulation of enzymes required for fatty acid and cholesterol metabolism have been extensively investigated using various transgenic and KO mice models. This detailed analysis has contributed to a better understanding of how lipid metabolism is regulated (Shimano et al. 1996; Shimano et al. 1997; Matsuda et al. 2001; Liang et al. 2002) . Regulation of ′ UTR region, but with the putative miR-96-binding site deleted was also cloned into a similar plasmid (pmtINSIG2). A plasmid containing the 3 ′ UTR of human FOXO1 was used as a positive control. Plasmids were then co-transfected into CHO-K1 cells with miR-96 mimics. Cell extracts were prepared and the firefly and Renilla luciferase activities measured. Firefly luciferase activity was normalized to the Renilla luciferase activity. Values shown are means ± S.E. (n = 4 wells).
non-coding genes by SREBPs, particularly miRNAs, has also been investigated (Jeon et al. 2013) . For example, SREBP-2 was found to induce transcription of miR-96, -182, and -183, from a single region. Our study has shown that miR-96 targets the 3 ′ UTR of INSIG2, reducing its expression and thereby accelerating SREBP processing. This results in an increase in the abundance of the nuclear forms of SREBP-1 and -2, both of which have further roles in SREBP regulation. Another miRNA from the same transcript, miR-182 was shown to increase SREBP levels by inhibiting Fbxw7 (Jeon et al. 2013 ). We were unable to determine a role for miR-183 in our study and found no effect on INSIG or SREBP activation. miR-96 and miR-183 both have an additional role in controlling FOXO1, a major transcription factor in the liver that regulates glucose production genes, such as glucose 6-phophatase and phosphoenolpyruvate carboxykinase. The FOXO1 3 ′ UTR was used as a positive control in our study of regulation by miR-96 and miR-183. Although FOXO1 does not directly regulate SREBPs, a reduction in FOXO1 may increase the flow of substrates into the lipid synthesis pathway. By reducing the flow of glucose 6-phosphate into glucose production, it may be more available for fatty acid and cholesterol synthesis. The expression and subsequent regulation of miRNAs transcribed together may be both a way to rapidly activate SREBPs and a method to increase fatty acid and cholesterol synthesis. In concert with other regulation methods, including transcriptional and post-translational mechanisms, our study reveals that miRNAs act to control SREBP levels and also play a role in directing metabolic flow. . mRNA expression levels of SREBP target genes in human fibroblasts transfected with miR-96. Total RNA was prepared from cells transfected with either miR-NC or a miR-96 mimic. The expression levels of the target genes of SREBP-1 (FAS, SCD-1, and ELOVL6) and SREBP-2 (HMG-CoA synthase and HMG-CoA reductase) were measured. The expression levels in cells without transfection were regarded as 1.0 and levels in other groups determined relative to this group. Data were normalized to a cyclophilin endogenous control (n = 2). FAS, fatty acid synthase; SCD-1, stearoyl-CoA desaturase; ELOVL6, elongation of very long chain fatty acid-like family member 6.
